Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Cyclophosphamide + Filgrastim in Follicular Low-Grade NHL
NCT00002501Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Oct 1992
- Primary completion
- Jul 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in follicular lymphoma (FL), sponsored by Cancer and Leukemia Group B. Started Oct 1992; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00002501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002501.